General Announcement::Tender Offer & Consent Solicitation

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
19-Mar-2021 09:01:01
Status
New
Announcement Sub Title
Tender Offer & Consent Solicitation
Announcement Reference
SG210319OTHRV3LK
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary and Compliance Officer
Effective Date and Time of the event
19/03/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
Invitation by Glenmark Pharmaceuticals Limited (the Company ) to the holders of its outstanding U.S.$200,000,000 2.00 per cent. Resettable Onward Starting Equity linked Securities Due 2022 ( Bonds ) to tender such Bonds for purchase by the Company for cash and to approve the amendment to the optional put notice period of the Bonds.

Attachments

SGX_Operation_Committee_Outcome_SIGNED.pdf
Total size =348K